Disease activity related catecholamine response of lymphocytes from patients with rheumatoid arthritis.
In patients with chronic rheumatic diseases, a decreased density of beta 2-adrenergic receptors (beta 2R) on peripheral blood mononuclear cells (PBMC) could be demonstrated negatively correlating with various disease activity parameters. The aim of the present study was to determine the impact of this decrease on catecholamine response of PBMC from patients with rheumatoid arthritis (RA) in vitro. PBMC from 17 patients with RA and 6 healthy blood donors (HD) were investigated. The effects of epinephrine (E) and norepinephrine (NE) on PBMC proliferation were studied using cells activated with phytohemagglutinin (PHA) and monoclonal anti-CD3-antibodies (OKT3), respectively. The results revealed that lymphocytes of patients with RA showed a significantly reduced influence of catecholamines on PBMC function. In RA patients with high disease activity only, a shift to alpha 1-adrenergic-mediated catecholamine effects upon PBMC reactivity could be observed. The study demonstrates the intricate relationship between PBMC reactivity and catecholamine effects that is mediated via alpha- and beta-adrenergic receptors due to disease activity. In this respect the altered catecholamine response of PBMC from patients with RA may contribute to the pathogenic process of RA.
Wahle
M
M
Department of Medicine, Polyclinic, Philipps-University, Marburg, Germany. wahle@mailer.uni-marburg.de
Krause
A
A
Ulrichs
T
T
Jonas
D
D
von Wichert
P
P
Burmester
G R
GR
Baerwald
C G
CG
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000473:pathology* / Q000503:physiopathology; D017252:CD3 Complex / Q000276:immunology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D012016:Reference Values
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D010835:Phytohemagglutinins; D011943:Receptors, Adrenergic, beta; D009638:Norepinephrine; D004837:Epinephrine